Stimulation of a spermatogenesis at men gonadotrophins and an antiestrogen at a pathospermia and infertility
https://doi.org/10.14341/probl201662237-41
Abstract
Aim — to investigate the methods of treatment, directed on increase in quantity of spermatozoa in an ejaculate.
Material and methods. In investigation was used: chorionic gonadotrophin, anti-estrogen, recombinant preparations FSH, and also their combinations.
Results. The worst efficiency (10%) was noted when using monotherapy by preparation HCG. Efficiency of monotherapy by a preparation of clomiphene was higher and made 20% concerning conception, and 63% concerning an oligoteratozoospermiya. Efficiency of the combined therapy of HCG in combination with recombinant FSH was 40% concerning conception, and 87% concerning an oligoteratozoospermiya.
Conclusion. At the same time the studied types of the stimulating therapy are effective, safe and don’t lead to development of side effects.
About the Authors
Nataliya S. Kravtsova
Endocrinology Research Centre
Russian Federation
MD, PhD-student
Russian Federation
MD, PhD-student
Roman V. Rozhivanov
Endocrinology Research Centre
Russian Federation
MD, PhD
Russian Federation
MD, PhD
Dmitriy G. Kurbatov
Endocrinology Research Centre
Russian Federation
MD, PhD, Head of the Urology department, Clinical Endocrinology Institute
Russian Federation
MD, PhD, Head of the Urology department, Clinical Endocrinology Institute
References
1. Всемирная организация здравоохранения. Руководство по лабораторному исследованию эякулята человека и взаимодействия сперматозоидов с цервикальной слизью. 4-е изд. – М.; 2001. – 144 с. [Who. Rukovodstvo po laboratornomu issledovaniyu eyakulyata cheloveka i vzaimodeystviya spermatozoidov s tservikal’noy sliz’yu. 4th edition. Moscow; 2001. 144 p. (In Russ.)].
2. Андрология. Мужское здоровье и дисфункция репродуктивной системы / Под ред. Э. Нишлага, Г.М. Бере. – М.; 2005. – 554 с. [Andrology. Man’s health and reproductive system dysfunction. Ed by E. Nishlag, G.M. Bere. Moscow; 2005. 554 p. (In Russ.)].
3. Yang L, Zhang SX, Dong Q, et al. Application of hormonal treatment in hypogonadotropic hypogonadism: more than ten years experience. Int Urol Nephrol. 2012;44(2):393-399. doi: 10.1007/s11255-011-0065-0.
4. Amirzargar MA, Eavangi M, Basiri A, et al. Comparison of recombinant human follicle stimulating hormone (RHFSH), human chorionic gonadotropin (HCG) and human menopausal gonadotropin (HMG) on semen parameters after varicocelectomy: a randomized clinical trial. Iran J Reprod Med. 2012;10(5):441-452. PMC4169682.
5. Sinisi AA, Esposito D, Bellastella G, et al. Efficacy of recombinant human follicle stimulating hormone at low doses in inducing spermatogenesis and fertility in hypogonadotropic hypogonadism. J Endocrinol Invest. 2010;33(9):618-623. doi: 10.1007/bf03346659.
6. Chua ME, Escusa KG, Luna S, et al. Revisiting oestrogen antagonists (clomiphene or tamoxifen) as medical empiric therapy for idiopathic male infertility: a meta-analysis. Andrology. 2013;1(5):749-757. doi: 10.1111/j.2047-2927.2013.00107.x. doi: 10.14341/probl201662237-41
Supplementary files
Review
For citations:
Kravtsova N.S., Rozhivanov R.V., Kurbatov D.G. Stimulation of a spermatogenesis at men gonadotrophins and an antiestrogen at a pathospermia and infertility. Problems of Endocrinology. 2016;62(2):37-41. https://doi.org/10.14341/probl201662237-41
Views:
1297
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND 4.0).
Email this article 
.jpg){kind=logo}
